IMM

ImmuPharma plc (LON:IMM), the specialist drug discovery and development company, is pleased to announce its final results for the twelve months ended 31 December 2019. Key Highlights (including post Period review)

Lupus is a chronic autoimmune condition in which the immune system attacks its own tissues. People with lupus are at higher risk of infections, and those with lupus who develop

Our Health Educator Network—health-care professionals and lupus specialists who provide individualized answers—have seen their inquires triple in the last week. The following are questions they’ve been frequently asked and their

Researchers suggest maintaining disease remission in people with lupus, especially during a pandemic infection, is extremely important to avoid unnecessary office and emergency room visits, and hospitalizations, all of which increase potential

There is no evidence that taking hydroxychloroquine (Plaquenil) is effective in preventing a person from contracting the coronavirus (COVID-19). People with lupus should follow the guidance of their doctor and

A 2-year, sustained mean blood pressure of 130-139/80-89 mm Hg — now considered the threshold for stage 1 hypertension by the American College of Cardiology and the American Heart Association

ImmuPharma PLC (LON:IMM), the specialist drug discovery and development company, has today announced subscriptions to raise £1.5 million through the issue of 15,000,000 new ordinary share of 10 pence each

Lupus isn’t that common but when it strikes it can be very ­serious, even life-threatening. The story of the singer and ­actress Selena Gomez is a case in point. All lupus sufferers

When you are not feeling well, all you want to do is pinpoint why and get proper treatment. For patients with lupus, however, the journey to a correct diagnosis can

Experts say that people with chronic conditions that affect the immune system, such as lupus and diabetes, are at a higher risk of developing severe complications from coronavirus. Here’s what